Related Parties

3 Months Ended

Mar. 31, 2016

Related Party Transactions [Abstract]

Related Parties

10. Related Parties:

Dr. August J. Troendle, an officer and director of Medpace, which provides clinical development services to the Company, is a beneficial owner of more than 5% of the Company’s common shares. The Company incurred $373 of clinical development service fees under its priority access agreement and a master services agreement with Medpace for the three months ended March 31, 2016 (three months ended March 31, 2015 - nil). Additionally, the Company has recorded $2,150  of prepaid expenses as of March 31, 2016 (December 31, 2015 – $2,314) for future clinical development services under such agreements with Medpace.